Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by 99942Apophison Nov 08, 2021 9:52am
640 Views
Post# 34099264

World Bladder Cancer

World Bladder Cancer

Bladder cancer statistics

Bladder cancer is the tenth most common cancer worldwide

Bladder cancer is the sixth most commonly occurring cancer in men and the 17th most commonly occurring cancer in women. There were almost 550,000 new cases in 2018. The top 25 countries with the highest incidence of bladder cancer in 2018 are given in the tables below.

The Continuous Update Project Panel judged there is strong evidence that drinking water containing arsenic increases the risk of bladder cancer. There is some evidence that consuming fruit and vegetables and drinking tea might decrease the risk of bladder cancer.

> Read about all the evidence in our Third Expert Report.

Age-standardised rates are used in the tables. This is a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardisation is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of dying from cancer.

Bladder cancer rates: both sexes

Lebanon had the highest rate of bladder cancer in 2018, followed by Greece.

Rank Country Age-standardised rate per 100,000
1 Lebanon 25.0
2 Greece 21.2
3 Denmark 17.9
4 Hungary 16.6
5= Albania 16.3
5= Netherlands 16.3
7 Belgium 16.2
8 Italy 15.9
9 Germany 15.7
10 Spain 15.6
11 Serbia 15.1
12 Croatia 13.7
13= Iceland 13.5
13= Poland 13.5
15 Norway 13.0
16 Syria 12.9
17 Switzerland 12.7
18 Malta 12.6
19 Bulgaria 12.1
20 US 12.0
21= Turkey 11.9
21= Egypt 11.9
23= Czech Republic 11.7
23= Israel 11.7
23= Latvia 11.7

<< Previous
Bullboard Posts
Next >>